Home » Newsletters » BioWorld Science

BioWorld Science

May 9, 2011

View Archived Issues

Incozen and Rhizen Pharmaceutical design new CRAC inhibitors

Achaogen presents novel antibacterial aminoglycosides

T cells transduced with GD2-specific receptor 14.G2aCD28zeta lyse Ewing sarcoma cells in vitro

Water-soluble ciclosporin derivative modulates immune responses in dry eye disease

FDA approves Afinitor to treat advanced pancreatic neuroendocrine tumors

Safety monitoring committee finds no significant concerns in Nymox's two pivotal trials of NX-1207

Pfizer discovers potent and selective inhibitors of phosphodiesterase 8B

Erythropoietin-derived peptide pHBSP has anti-inflammatory effects in rodent models of retinopathy

Interim phase I/II data suggest MP-0112 is efficacious in AMD and DME

Chugai Pharmaceutical reflects on first quarter of 2011

Zafgen claims novel methionine aminopeptidase 2 inhibitors

Siena Biotech patents new Wnt signaling inhibitors

Bristol-Myers Squibb divulges new inhibitors of HIV integrase

New IDO-1 inhibitors identified for cancer therapy

Concert Pharmaceuticals' C-10068 has anticonvulsant and neuroprotective activity

PMX-30063 shows in vitro activity against NDM-1-producing drug-resistant bacteria

Intercell begins confirmatory trial of vaccine enhancement patch in pandemic influenza

Dainippon Sumitomo Pharma sets Japanese launch date for Surepost

European phase III Diamyd trial in type 1 diabetes does not meet primary endpoint

Chugai seeks approval for new indications of Herceptin in Japan

Pfizer returns R-343 rights to Rigel Pharmaceuticals

Axcan Pharma/Eurand changes name to Aptalis Pharma

Alkermes and Elan Drug Technologies to merge to form new company

TGen licenses selective histone deacetylase inhibitors to Oncoholdings

EMA agrees to pediatric investigational plan for rFIXFc in hemophilia B

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 10, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...